Effect of high glucose concentrations on prostacyclin-stimulating factor mRNA expression in cultured aortic smooth muscle cells

Diabetologia

Volumn 41, Issue 2, 1998, Pages 134-140

  Ono, Y ^a   Umeda, F ^a   Kunisaki, M ^a   Sekiguchi, N ^a   Hashimoto, T ^a   Nawata, H ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Aortic smooth muscle cells; High glucose; Prostacyclin stimulating factor; Protein kinase C

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; GLUCOSE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTACYCLIN; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; AORTA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; NONHUMAN; OSMOLALITY; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; BIOLOGICAL FACTORS; BLOTTING, NORTHERN; CATTLE; CELLS, CULTURED; EPOPROSTENOL; GLUCOSE; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASE C; RNA, MESSENGER;

EID: 0031912360     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050881     Document Type: Article

References (46)

1. Mandarino LJ (1992) Current hypotheses for the biochemical basis of diabetic retinopathy. Diabetes Care 15: 1892-1901
2. Shami SK, Chittenden SJ (1991) Microangiopathy in diabetes mellitus: features, complications and investigation. Diabetes Res 17: 157-168
3. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 320: 977-986
4. Greene DA, Lattimer SA, Sima AF (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599-606
5. Brownlee M, Cerami A, Vlassara H (1989) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 320: 1161-1165
6. Williamson JR, Chang K, Frangos M, et al. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813
7. Larkins RG, Dunlop ME (1992) The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35: 499-504
8. Tesfamariam B, Brown ML, Keykin D, Cohen RA (1990) Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 85: 929-932
9. Kunisaki M, Bursell SE, Clermont AC et al. (1995) Vitamin E prevents diabetes-induced abnormal retinal blood flow. Am J Physiol 269:E239-E246
10. Inoguchi T, Battan R, Handler E, Sportsman JR, Haeth W, King GL (1992) Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89: 11059-11063
11. Kunisaki M, Bursell SE, Umeda F, Nawata H, King GL (1994) Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43: 1372-1377
12. Craven PA, DeRubertis (1989) Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. J Clin Invest 83: 1667-1675
13. +-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest 96: 733-740
14. King GL, Shiba T, Oliver J, Inoguchi T, Bursell SE (1994) Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Ann Rev Med 45: 179-188
15. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL (1994) Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43: 1122-1129
16. Williams B, Schrier RW (1993) Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92: 2889-2896
17. Christensen NJ (1972) Plasma catecholamines in long-term diabetes with and without nephropathy and in hypophysectomised subjects. J Clin Invest 51: 779-787
18. Christlieb AR, Kaldany A, D'Elia JA (1976) Plasma renin activity and hypertension in diabetes mellitus. Diabetes 25: 969-974
19. Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665
20. Moncada S, Vane JR (1978) Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull 34: 129-135
21. 2) into a platelet anti-aggregatory substance which contracts isolated bovine coronary arteries. Prostaglandins 9: 907-916
22. 2 analogues with increased stability on platelet cAMP content and aggregation. Thromb Res 17: 673-681
23. Watanabe J, Umeda F, Inoguchi T, Ibayashi H (1985) Decreased prostacyclin production and platelet abnormalities in diabetes mellitus. J Japanese Diabetes Soc 28: 1229-1334
24. Inoguchi T, Umeda F, Watanabe J, Ibayashi H (1987) Stimulatory activity on prostacyclin production decreases in sera from streptozotocin-induced diabetic rats. Diabet Res Clin Pract 3: 243-248
25. Inoguchi T, Umeda F, Ono H, Kunisaki M, Watanabe J, Nawata H (1989) Abnormality in prostacyclin-stimulatory activity in sera from diabetics. Metabolism 38: 837-842
26. Yamauchi T, Umeda F, Masakado M, Ono Y, Nawata H (1993) Serum-free conditioned medium of human diploid fibroblast cells contains an activity that stimulates prostacyclin production by cultured bovine aortic endothelial cells. Biochem Mol Biol 31: 65-71
27. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H (1994) Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J 303: 591-598
28. Masakado M, Umeda F, Yamauchi T, Ishii H, Ono Y, Nawata H (1994) Human fibroblast cells produce a factor that stimulates prostacyclin synthesis by vascular endothelial cells. Thromb Res 76: 513-524
29. Ono Y, Hashimoto T, Umeda F et al. (1994) Expression of prostacyclin-stimulating factor, a novel factor, in tissues of Wistar rats and in cultured cells. Biochem Biophys Res Commun 202: 1490-1496
30. Masakado M, Umeda F, Takei A, Hashimoto T, Sueishi K, Nawata H (1995) Immunohistochemical localization of a novel peptide, prostacyclin-stimulating factor (PSF), in human tissues. Thromb Haemostas 74(6):1407-1410
31. Ross R (1971) The smooth muscle cells. II. Growth of smooth muscle cells in culture and formation of elastic fibers. J Cell Biol 50: 172-186
32. Sakakibara F, Hotta N, Koh N, Sakamoto N (1993) Effect of high glucose concentration and epalrestat on sorbitol and myo-inositol metabolism in cultured rabbit aortic smooth muscle cells. Diabetes 42: 1594-1600
33. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
34. Maniatis T, Fritsch EF, Sambrook J (1989) Molecular cloning: a Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory, NY
35. Kawakami M, Ishibashi S, Ogawa H, Murase T, Takaku F, Shibata S (1986) Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells. Biochem Biophys Res Commun 141: 482-487
36. Bhatia P, Taylor WR, Greenberf H, Wright JA (1994) Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for Northern blot analysis of cell lines of varying malignant potential. Anal Biochem 216: 223-226
37. Johnson M, Harrison HE, Raftery AZ (1979) Vascular prostacyclin may be reduced in diabetes in man. Lancet 1: 325-326
38. Silberbauer K, Schernthaner G, Sinzinger H, Piza-Katzer H, Winter M (1979) Decreased vascular prostacyclin in juvenile-onset diabetes. N Eng J Med 300: 366-367
39. Dollery CT, Friedman LA, Hensby CN, et al. (1979) Circulating prostacyclin may be reduced in diabetes. Lancet 2: 1365
40. Aanderud S, Krane K, Nordy A (1985) Influence of glucose, insulin and sera from diabetic patients on prostacyclin synthesis in vitro in cultured human endothelial cells. Diabelologia 28: 641-644
41. Dusting GJ, Moncada S, Vane JR (1977) Disappearance of prostacyclin in the circulation of the dog. Br J Pharmacol 62: 414-415
42. Crall F, Roberts WC (1978) The extramural and intramural coronary arteries in juvenile diabetes mellitus. Am J Med 64: 221-230
43. Sinzinger H, Feigl W, Silberbauer K (1979) Prostacyclin generation in atherosclerotic arteries. Lancet 2: 469
44. Ono H, Umeda F, Inoguchi T, Nawata H (1989) Decrease in insulin binding to aortic endothelial cells cultured with high glucose concentration. Diabet Res Clin Pract 6: 115-119
45. Ono Y, Umeda F, Sekiguchi N, Hashimoto T, Masakado M, Nawata H (1997) Reduced expression of a novel peptide, prostacyclin-stimulating factor (PSF), in the kidneys of streptozotocin-induced diabetic rats. J Diab Comp (in press)
46. Sekiguchi N, Umeda F, Masakado M, Ono Y, Hashimoto T, Nawata H (1997) Immunohistochemical study of prostacyclin-stimulating factor (PSF) in the diabetic and atherosclerotic human coronary artery. Diabetes 46: 1627-1632